Results 41 to 50 of about 3,408,094 (285)
Hydrophobic Modification of Wood Using Tetramethylcyclotetrasiloxane
Polymers, 2022 Hydrophobic surfaces have aroused considerable attention because of their extensive potential applications. In this work, we developed a facile strategy for fabricating hydrophobic and anti-fouling surfaces on wood substrates. The modification was accomplished simply by immerging wood into the tetramethylcyclotetrasiloxane (D4H) modifier solution for 5
Mingwei Tang +5 more
openaire +2 more sources
From mice to humans—divergent strategies for intestinal homeostasis and regeneration
FEBS Letters, EarlyView.Recent advances such as organoid genome editing, xenotransplantation, imaging, and whole‐genome sequencing have enabled direct studies of human intestinal stem cells (ISCs). These studies reveal species‐specific features, including slower ISC proliferation, distinct injury responses, slower somatic mutation accumulation in humans, and an inverse ...
Keiko Ishikawa +2 more
wiley +1 more source
Molecular Oncology, EarlyView.In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
COST Action FP1407 WG1 and WG4 meeting Wood modification in Europe: processes, products, applications,, 2018 Presents and overview of wood modification activities and uses in Slovenia. As of early 2018, Slovenia has two main providers of thermally modified wood. One company developed its own process while the other firm provides treatment. In addition to Slovenia’s wood modification industry, researchers in the country are deeply involved in various aspects ...
Kitek Kuzman, Manja +2 more
openaire +3 more sources
Wood modification technologies - a review
, 2017 : The market for new durable products of modified wood has increased substantially during the last few years, especially in Europe. This increased interest depends partly on the restricted use of toxic preservatives due to increased environmental concern,
D. Sandberg, A. Kutnar, G. Mantanis
semanticscholar +1 more source
Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers
Molecular Oncology, EarlyView.This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel +6 more
wiley +1 more source
Molecular Oncology, EarlyView.Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
Thermal Modification of Spruce and Maple Wood for Special Wood Products
Polymers, 2022 This article presents a proposal of thermal modification of Norway spruce and sycamore maple for special wood products, mainly for musical instruments. Selected physical and acoustical characteristics (PACHs), including the density (ρ), dynamic modulus of elasticity along the wood grain (EL), specific modulus (Esp), speed of sound along the wood grain (
Anna Danihelová +4 more
openaire +2 more sources
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Molecular Oncology, EarlyView.Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source